OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miRNA-Based Therapeutics in Breast Cancer: A Systematic Review
Anna Grimaldi, Marco Salvatore, Mariarosaria Incoronato
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential
Junjiang Fu, Saber İmani, Mei-Yi Wu, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4723-4723
Open Access | Times Cited: 39

Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives
Farhad Seif, Zahra Torki, Hamidreza Zalpoor, et al.
Molecular Therapy — Oncolytics (2023) Vol. 28, pp. 132-157
Open Access | Times Cited: 29

Crosstalk between miRNAs and DNA Methylation in Cancer
Michela Saviana, Patricia Le, Lavender Micalo, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1075-1075
Open Access | Times Cited: 23

Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment
Sonali Shinde, Sakeel Ahmed, Jonaid Ahmad Malik, et al.
Biology (2023) Vol. 12, Iss. 3, pp. 467-467
Open Access | Times Cited: 21

Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer
Ankita Dey, Moumita Kundu, Subhayan Das, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188692-188692
Closed Access | Times Cited: 27

Forging New Therapeutic Targets: Efforts of Tumor Derived Exosomes to Prepare the Pre-Metastatic Niche for Cancer Cell Dissemination and Dormancy
Ranvir Bhatia, Joanna Chang, Jessian L. Munoz, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1614-1614
Open Access | Times Cited: 16

Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target
Xianlong Fang, Xue-ping Cao, Jun Xiao, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 3, pp. 223-240
Closed Access | Times Cited: 5

Cellular and Exosomal MicroRNAs: Emerging Clinical Relevance as Targets for Breast Cancer Diagnosis and Prognosis
Faith Mokobi Zablon, Parth Desai, Kristen Dellinger, et al.
Advanced Biology (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 5

Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies
Aimi Syamima Abdul Manap, Aini Athirah Wisham, Fei Wen Wong, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5

Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer
Luis M. Ruiz‐Manriquez, Cynthia Villarreal‐Garza, Javier A. Benavides‐Aguilar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9984-9984
Open Access | Times Cited: 10

Non-coding RNAs Affect Breast Cancer Development Through the Notch Signaling Pathway: An Overview
Alireza Ahmadi, Amin Moqadami, Mohammad Khalaj‐Kondori, et al.
Gene Expression (2024) Vol. 23, Iss. 1, pp. 44-56
Open Access | Times Cited: 3

Urinary miRNAs as a Diagnostic Tool for Bladder Cancer: A Systematic Review
Anna Grimaldi, Cristina Lapucci, Marco Salvatore, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2766-2766
Open Access | Times Cited: 17

Recent advances in novel miRNA mediated approaches for targeting breast cancer
Seyedeh Melika Ahmadi, Shervin Amirkhanloo, Rezvan Yazdian–Robati, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 8, pp. 777-793
Closed Access | Times Cited: 9

MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential
Junjiang Fu, Saber İmani, Mei-Yi Wu, et al.
(2023)
Open Access | Times Cited: 9

The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective
Valentina Fogazzi, Marcel Kapahnke, Alessandra Cataldo, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5326-5326
Open Access | Times Cited: 14

Inhibition of MiR-155 Using Exosomal Delivery of Antagomir Can Up-Regulate PTEN in Triple Negative Breast Cancer
Javad Razaviyan, Majid Sirati‐Sabet, Ali Tafti, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 24, Iss. 14, pp. 1664-1676
Closed Access | Times Cited: 2

Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy
Liliana-Roxana Balahura, Sorina Dinescu, Marieta Costache
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3245-3245
Open Access | Times Cited: 7

Role of the Mediator Complex and MicroRNAs in Breast Cancer Etiology
Edio Maldonado, Sebastián Morales, Fabiola Urbina, et al.
Genes (2022) Vol. 13, Iss. 2, pp. 234-234
Open Access | Times Cited: 11

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
Matthew G. Davey, Andrew McGuire, Máire‐Caitlín Casey, et al.
Journal of the American College of Surgeons (2022) Vol. 236, Iss. 2, pp. 317-327
Open Access | Times Cited: 11

MicroRNAs in Epithelial–Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy
Fu Peng, Huali Fan, Li Sui, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7526-7526
Open Access | Times Cited: 14

Obesity as a Risk Factor for Breast Cancer—The Role of miRNA
Karolina Hanusek, Jakub Karczmarski, Anna Litwiniuk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15683-15683
Open Access | Times Cited: 10

The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis
Antonis Tsintarakis, Chara Papalouka, Christina Kontarini, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1361-1361
Open Access | Times Cited: 5

Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis
William Duggan, Emer O’Connell, Jochen H.M. Prehn, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 10, pp. 2451-2467
Open Access | Times Cited: 9

The role of unfolded protein response-associated miRNAs in immunogenic cell death amplification: A literature review and bioinformatics analysis
Mahdieh Azizi, Sadra Salehi-Mazandarani, Parvaneh Nikpour, et al.
Life Sciences (2022) Vol. 314, pp. 121341-121341
Closed Access | Times Cited: 9

Page 1 - Next Page

Scroll to top